Join the Oncology Voice Network. Join for Free
Mastering the Medical Affairs Professional Role: Inside and Out
Medical Science Liaison Key Opinion Leader MSL Career Transition Medical Affairs Strategies Effective KOL Engagement

Mastering the Medical Affairs Professional Role: Inside and Out


Share This Article


Summary

In this episode, Tom Caravela welcomes Kent Christofferson to discuss his career journey and insights into the MSL role. Kent shares his transition from academia to industry, highlighting the importance of mastering the MSL role and thinking like a Key Opinion Leader (KOL). He delves into the value proposition of MSLs, the significance of team effectiveness, and the challenges of handling multiple roles. The conversation covers compliance, technology, and future medical affairs directions, emphasizing digital engagement and the shift towards relationship-based interactions. Kent concludes with strategies for effective KOL engagement and the importance of leadership support in the evolving MSL landscape.

Kent Christopherson, Senior  Director, Medical Affairs at Orchard Therapeutics discusses the art of Mastering the Medical Affairs Professional Role Internally and Externally.

Kent shares…

πŸ‘‰ Why MSLs need to “think like a KOL”

πŸ‘‰ The importance of Individual Development Plans

πŸ‘‰ Integrated Team Effectiveness Model- (ITEM) ref: 2006, Louise Lemieux-Charles, Wendy L McGuire

πŸ‘‰ Why clinical insights is the currency for MSL value internally

πŸ‘‰ Why it is vital to understand what KOLs motivation is in order to ensure value and meet deliverables

Click for Source
Medical Science Liaison, Key Opinion Leader, MSL Career Transition, Medical Affairs Strategies, Effective KOL Engagement

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN